Quidel Corporation (QDEL)

NASDAQ
129.60
+2.30(+1.81%)
Pre Market
129.60
0.00(0.00%)
- Real-time Data
  • Volume:
    663,512
  • Bid/Ask:
    126.02/132.29
  • Day's Range:
    125.39 - 132.26

QDEL Overview

Prev. Close
129.6
Day's Range
125.39 - 132.26
Revenue
1.66B
Open
128.26
52 wk Range
96.05 - 305.07
EPS
18.59
Volume
663,512
Market Cap
5.48B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
903,718
P/E Ratio
6.97
Beta
0.07
1-Year Change
31.05%
Shares Outstanding
42,319,115
Next Earnings Date
May 12, 2021
What is your sentiment on Quidel Corporation?
or
Market is currently closed. Voting is open during market hours.

Quidel Corporation News

Quidel Corporation Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellNeutral
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellSell

Quidel Corporation Company Profile

Quidel Corporation Company Profile

Employees
1370

Quidel Corp. is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: rapid immunoassays, cardiac immunoassay, specialized diagnostic solutions and molecular diagnostic solutions. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of many diseases and medical conditions, including infectious diseases, cardiovascular diseases and conditions, women’s health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Amplivue, Lyra and Thyretain.

Read More
  • most stocks are 52 weeks highs this one almost 52 weeks low who is selling$122 this one and buying 52 high stocks that's weird
    0
    • I m down almostP down I don't mind P more down
      0
    • I m down P I don't mind %5
      0
    • it's okay I m down P I don't care %5
      0
  • it's down %100 in 1,5 month is ceo still alive ?
    0
    • “Quidel applauds the Biden Administration’s urgent and comprehensive approach to bringing the benefits of rapid, routine and equitable coronavirus testing to America’s classrooms, underserved communities and rural areas,” said Douglas Bryant, president and CEO of Quidel Corporation. “Frequent testing has proven to be a critical tool for both empowering people to take charge of their own health and allowing large institutions, businesses, sports and entertainment venues and enumerable other aspects of society to reopen safely and remain so.”
      0
      • Quidel is currently building out a new manufacturing facility in Carlsbad, CA dedicated to the production of Quidel’s popular QuickVue® line of products. The 128,000 square foot facility will be the company’s highest-volume production plant in the world and is expected to produce 600 million QuickVue® rapid antigen tests for the detection and diagnosis of COVID-19 infections.
        0
    • Time to buy for me...   ( JP Morgan Adjusts Price Target for Quidel to $120 From $140, Maintains Underweight Rating 03/11/2021 | 10:04am EST )
      2
      • $$130 wowww still selling
        0
        • $142 who is selling 🤣
          0
          • 🤣🤣 who is selling$153
            0
            • Why is it going so down? Report was good
              0
              • if you selling this $185 I m happy for you losing money 😆😆😂
                3
                • ,Alpha Pro Tech, Ltd. (APT), UP 17%, made face mask
                  0
                  • zacks is the most worst analyst rating system there is- this proves it
                    0
                    • I think after earnings it will be over $280
                      1
                  • nothing we can do and feel sorry for the buy and holds
                    1
                    • Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. QDEL is currently sporting a Zacks Rank of #1 (Strong Buy).
                      0
                      • korea seagen company which makes covid-19 diagnosis kit drops down to about to 5 billion dollar  but annual operating fit is 0.6billion dollar very very cheapest i ever seen in the stock market  it can detect 100% covid-19 virus from no symptoms and transformed infection korea stock market made cost down for taking out stocks from personal investor
                        0
                        • SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to market its QuickVue® SARS Antigen test, a point-of-care assay for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nares (NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms.
                          0
                          • Bull/Bear Power (13) 2.1280  => BUY    Something is changing here
                            0
                            • QUANTITATIVE STOCK REPORT | November 27, 2020 | NasdaqGS : QDELQuidel CorporationRecommendation [as of November 25, 2020]:STRONGBUY Risk Evaluation: MODERATE Price: 188.00 (Nov 27, 2020 close) Trading Currency: USDCountry: United StatesGICS Sector: Health Care Sector Ranking: overweight SPGMI's Quality Ranking: C GICS Industry: Health Care SuppliesBusiness Summary: Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a contd...Quantitative Model Drivers[as of November 25, 2020]Price Performance
                              0
                              • Jp morgan downgrades- does that mean its a buy? ;) A rated on seeking alpha
                                0
                                • january over $250
                                  0
                                  • Test kits will be more needed with vaccines especially on COVID-19. This one is totally different from influenza vaccination ways.
                                    0
                                    • Vaccination may need pre-screening COVID test on asymptomatic cases. Korean scientists began to mention about it in news media. Let's monitor CDC guidelines.
                                      0
                                      • who sells $187 😂I hope they sell more I want to buy more
                                        0
                                        • $175 please. Thanks
                                          1
                                          • No
                                            0
                                        • Why such a big fall today?
                                          0
                                          • Because the vaccine is approching to success
                                            0
                                        • Soon 310
                                          0
                                          • Where did you get that from?
                                            0
                                          • miért?
                                            0
                                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.